Search Results 1051-1060 of 13468 for monoclonal antibody
an anti-CD38 monoclonal antibody. - Permitted to be venetoclax or BCL-2 inhibitor exposed in previous lines of therapy. - Life expectancy ≥ 12 weeks ...
A Study Of JNJ-69086420, An Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (HK2) For Advanced Prostate Cancer · More about research at Mayo Clinic.
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
If you are eligible for a prescription treatment, such as monoclonal antibody therapy or antiviral medication, your health care provider would be able to ...
In this case, though, what the listener is referring to is a combination of two monoclonal antibodies that are given in two different ways. One of them is ...
Cohort A will enroll participants who have progressed on prior standard of care treatment with an anti-PD-1/PD-L1 antibody and a platinum-based chemotherapy ...
The earliest phase of monoclonal gammopathies is monoclonal ... When a person has MGUS, monoclonal ... antibody (anti-CD38) that targets a surface ...
... monoclonal gammopathy of thrombotic significance (MGTS). ... antibody detection. Researchers are beginning to ... Monoclonal gammopathy of thrombotic ...
What's the latest on monoclonal antibody therapies to treat COVID-19? Related Articles. Mayo Clinic recommendations for 2026-27 COVID-19 vaccines featured ...
... antibody-mediated rejection (AMR) at Week 52. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.